YS Biopharma Co., Ltd. Ordinary Shares Stock Price, News & Analysis
Company Description
YS Biopharma Co., Ltd. Ordinary Shares (NASDAQ: YS) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector. The company has a market capitalization of $192.1M, ranking #4,508 among all listed U.S. companies by market cap.
YS stock has declined 66.4% over the past year. Shares last traded at $1.02.
This page provides a comprehensive overview of YS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
YS Biopharma Co., Ltd. Ordinary Shares (YS) stock last traded at $1.02. Over the past 12 months, the stock has lost 66.4%. At a market capitalization of $192.1M, YS is classified as a micro-cap stock with approximately 188.3M shares outstanding.
Latest News
YS Biopharma Co., Ltd. Ordinary Shares has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include management, earnings, clinical trial, conferences. View all YS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
YS Company Profile & Sector Positioning
YS Biopharma Co., Ltd. Ordinary Shares (YS) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.